The medical centre, pathology and radiology company reported a 49.1 per cent rise in annual net profit to $118.9 million, versus guidance of between $120 and $125 million, and analyst forecasts of $120.5 million. June 2013 will reach between $370 and $380 million, resulting in earnings per share growth...
FULL ARTICLE AT Sydney Morning Herald